skinai.tech

What It Is

SkinAI is an integrated AI hardware-and-software solution for dermatology and hair health, headquartered in Madrid, Spain. Its products are split into two lines: Dermatoscopia IA, which supports dermoscopy and early skin cancer detection, and Salud Capilar IA, which analyzes scalp and hair conditions. The website emphasizes that its devices are already being used in real-world settings at reference hospitals and aesthetic centers in Madrid, and that validation is being carried out in collaboration with the dermatology department of Hospital 12 de Octubre.

Core Capabilities and Workflow

Its core offering is not a general-purpose AI tool, but a combination of dedicated imaging hardware, image AI models, and patient management software. The workflow for the scalp product includes capturing scalp images, automated AI analysis, and generating reports that include severity levels and follow-up changes. The system can produce results within seconds; the website claims AI analysis takes less than 5 seconds, and supports PDF reports, patient history, image records, and comparisons across multiple visits. On the dermoscopy side, the focus is on assisting early screening for skin cancer. Its validation study includes more than 3,000 unique images, using medical consensus and biopsy when indicated as validation methods.

Pricing and Integration

The website does not disclose pricing, plans, purchase or rental models, and there is no self-service trial. The main conversion path is booking a 15-minute demo. API, SDK, hospital HIS/EMR connectivity, and third-party system integration capabilities are not disclosed. The site only states that it can be incorporated into daily workflows, so institutions should further confirm deployment methods, device maintenance, data export, and system integration costs before procurement.

Pros and Cons

Its strengths are a clear vertical use case, covering image capture, analysis, grading, reporting, and follow-up; self-developed hardware with an emphasis on portability; and hospital collaboration plus clinical validation narratives, making it more credible than purely marketing-driven AI applications. The limitations are also obvious: key metrics such as sensitivity, specificity, and accuracy are not publicly disclosed; medical device certification, applicable countries, and clinical responsibility boundaries are not explained; and the crawled text does not include a privacy policy, patient image storage location, or compliance terms.

Who It’s For and Access from China

It is better suited for dermatologists, hospitals, clinics, pharmacies, aesthetic centers, and hair care institutions looking to improve diagnostic services and follow-up management. For users in China, website accessibility is unknown, and there is no visible Chinese interface, Chinese-language reports, RMB payment, or local after-sales information. If deployed in China, key issues to assess include medical device registration, cross-border data transfer, privacy compliance, and local alternatives such as domestic skin imaging AI or hair analysis device vendors.